Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002
- PMID: 16409656
- PMCID: PMC2870352
- DOI: 10.1017/S0950268805004553
Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002
Abstract
In a retrospective epidemiological study, 293 meningococcal disease patients hospitalized during 1985-2002, were examined for fatality and risk factors related to death. The overall case fatality rate (CFR) was 8.2%, but increased from 4% during 1985-1993 to 17% during 1994-2002. The latter 9-year period was characterized by more serogroup C infections and more patients with thrombocytopenia on admission to hospital. All patients categorized as meningitis on admission survived. Of the 24 patients who died, 21 had meningococcal skin rash on admission, 23 had an onset to admission time of < or =24 h, and 16 had severe septicaemia with hypotension and/or ecchymoses without meningitis on admission. By multivariate analyses, a short onset to admission time, >50 petechiae, thrombocytopenia and severe septicaemia on admission were associated with fatality. More lives could be saved through earlier admission to hospital. This can be achieved through more information to the public about the early signs of meningococcal septicaemia, with the recommendation to look for skin rash in patients with acute fever during the first day and night.
Figures
References
-
- B⊘vre K, Gedde-Dahl TW. Epidemiological patterns of meningococcal disease in Norway 1975–1979. NIPH Ann. 1980;3:9–22. - PubMed
-
- Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975–91. NIPH Ann. 1991;14:57–65. - PubMed
-
- Iversen BG, Aavitsland P. Meningococcal disease in Norway 1992–1995. Epidemiology and fatality. Scand J Infect Dis. 1996;28:253–259. - PubMed
-
- Halstensen A, Pedersen SH, Haneberg B, Bjorvatn B, Solberg CO. Case fatality of meningococcal disease in western Norway. Scand J Infect Dis. 1987;19:35–42. - PubMed
-
- Bjune G, Hoiby EA, Gronnesby JK et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet. 1991;338:1093–1096. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
… 